Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

The MEST score provides earlier risk prediction in lgA nephropathy.

Barbour SJ, Espino-Hernandez G, Reich HN, Coppo R, Roberts IS, Feehally J, Herzenberg AM, Cattran DC; Oxford Derivation, North American Validation and VALIGA Consortia; Oxford Derivation North American Validation and VALIGA Consortia.

Kidney Int. 2016 Jan;89(1):167-75. doi: 10.1038/ki.2015.322.

2.

Isolated endarteritis and kidney transplant survival: a multicenter collaborative study.

Sis B, Bagnasco SM, Cornell LD, Randhawa P, Haas M, Lategan B, Magil AB, Herzenberg AM, Gibson IW, Kuperman M, Sasaki K, Kraus ES; Banff Working Group.

J Am Soc Nephrol. 2015 May;26(5):1216-27. doi: 10.1681/ASN.2014020157. Epub 2014 Nov 7.

3.

The molecular phenotype of endocapillary proliferation: novel therapeutic targets for IgA nephropathy.

Hodgin JB, Berthier CC, John R, Grone E, Porubsky S, Gröne HJ, Herzenberg AM, Scholey JW, Hladunewich M, Cattran DC, Kretzler M, Reich HN.

PLoS One. 2014 Aug 18;9(8):e103413. doi: 10.1371/journal.pone.0103413. eCollection 2014.

4.

Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE).

Barisoni L, Nast CC, Jennette JC, Hodgin JB, Herzenberg AM, Lemley KV, Conway CM, Kopp JB, Kretzler M, Lienczewski C, Avila-Casado C, Bagnasco S, Sethi S, Tomaszewski J, Gasim AH, Hewitt SM.

Clin J Am Soc Nephrol. 2013 Aug;8(8):1449-59. doi: 10.2215/CJN.08370812. Epub 2013 Feb 7.

5.

Antibody mediated rejection associated with complement factor h-related protein 3/1 deficiency successfully treated with eculizumab.

Noone D, Al-Matrafi J, Tinckam K, Zipfel PF, Herzenberg AM, Thorner PS, Pluthero FG, Kahr WH, Filler G, Hebert D, Harvey E, Licht C.

Am J Transplant. 2012 Sep;12(9):2546-53. doi: 10.1111/j.1600-6143.2012.04124.x. Epub 2012 Jun 8.

6.

Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse.

Liu GC, Fang F, Zhou J, Koulajian K, Yang S, Lam L, Reich HN, John R, Herzenberg AM, Giacca A, Oudit GY, Scholey JW.

Diabetologia. 2012 Sep;55(9):2522-32. doi: 10.1007/s00125-012-2586-1. Epub 2012 Jun 1.

PMID:
22653270
7.

Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease.

Salvatore SP, Barisoni LM, Herzenberg AM, Chander PN, Nickeleit V, Seshan SV.

Clin J Am Soc Nephrol. 2012 Jun;7(6):914-25. doi: 10.2215/CJN.11751111. Epub 2012 Mar 29.

8.

Validation of the Oxford classification of IgA nephropathy.

Herzenberg AM, Fogo AB, Reich HN, Troyanov S, Bavbek N, Massat AE, Hunley TE, Hladunewich MA, Julian BA, Fervenza FC, Cattran DC.

Kidney Int. 2011 Aug;80(3):310-7. doi: 10.1038/ki.2011.126. Epub 2011 May 4.

9.

Molecular markers of injury in kidney biopsy specimens of patients with lupus nephritis.

Reich HN, Landolt-Marticorena C, Boutros PC, John R, Wither J, Fortin PR, Yang S, Scholey JW, Herzenberg AM.

J Mol Diagn. 2011 Mar;13(2):143-51. doi: 10.1016/j.jmoldx.2010.10.005.

10.

Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus.

Reich HN, Gladman DD, Urowitz MB, Bargman JM, Hladunewich MA, Lou W, Fan SC, Su J, Herzenberg AM, Cattran DC, Wither J, Landolt-Marticorena C, Scholey JW, Fortin PR.

Kidney Int. 2011 Apr;79(8):914-20. doi: 10.1038/ki.2010.525. Epub 2011 Jan 19.

11.

A molecular signature of proteinuria in glomerulonephritis.

Reich HN, Tritchler D, Cattran DC, Herzenberg AM, Eichinger F, Boucherot A, Henger A, Berthier CC, Nair V, Cohen CD, Scholey JW, Kretzler M.

PLoS One. 2010 Oct 18;5(10):e13451. doi: 10.1371/journal.pone.0013451.

12.

Podocyte injury and albuminuria in mice with podocyte-specific overexpression of the Ste20-like kinase, SLK.

Cybulsky AV, Takano T, Papillon J, Guillemette J, Herzenberg AM, Kennedy CR.

Am J Pathol. 2010 Nov;177(5):2290-9. doi: 10.2353/ajpath.2010.100263. Epub 2010 Oct 1.

13.

Insulin signaling to the glomerular podocyte is critical for normal kidney function.

Welsh GI, Hale LJ, Eremina V, Jeansson M, Maezawa Y, Lennon R, Pons DA, Owen RJ, Satchell SC, Miles MJ, Caunt CJ, McArdle CA, Pavenstädt H, Tavaré JM, Herzenberg AM, Kahn CR, Mathieson PW, Quaggin SE, Saleem MA, Coward RJM.

Cell Metab. 2010 Oct 6;12(4):329-340. doi: 10.1016/j.cmet.2010.08.015.

14.

Determinants of long-term graft outcome in transplant glomerulopathy.

John R, Konvalinka A, Tobar A, Kim SJ, Reich HN, Herzenberg AM.

Transplantation. 2010 Oct 15;90(7):757-64. doi: 10.1097/TP.0b013e3181efcffd.

PMID:
20838279
15.

Dysregulation of renal vitamin D metabolism in the uremic rat.

Helvig CF, Cuerrier D, Hosfield CM, Ireland B, Kharebov AZ, Kim JW, Ramjit NJ, Ryder K, Tabash SP, Herzenberg AM, Epps TM, Petkovich M.

Kidney Int. 2010 Sep;78(5):463-72. doi: 10.1038/ki.2010.168. Epub 2010 Jun 9.

16.

The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults.

Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, Cook HT, Feehally J, Roberts IS, Amore A, Alpers CE, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator SN, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo AB, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H.

Kidney Int. 2010 May;77(10):921-7. doi: 10.1038/ki.2010.43. Epub 2010 Mar 3.

17.

Human recombinant ACE2 reduces the progression of diabetic nephropathy.

Oudit GY, Liu GC, Zhong J, Basu R, Chow FL, Zhou J, Loibner H, Janzek E, Schuster M, Penninger JM, Herzenberg AM, Kassiri Z, Scholey JW.

Diabetes. 2010 Feb;59(2):529-38. doi: 10.2337/db09-1218. Epub 2009 Nov 23. Erratum in: Diabetes. 2010 Apr;59(4):1113-4.

18.

Vasculitis affecting the kidney.

John R, Herzenberg AM.

Semin Diagn Pathol. 2009 May;26(2):89-102. Review.

PMID:
19891303
19.

Our approach to a renal transplant biopsy.

John R, Herzenberg AM.

J Clin Pathol. 2010 Jan;63(1):26-37. doi: 10.1136/jcp.2009.067983. Epub 2009 Oct 22.

PMID:
19850567
20.

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.

Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H.

Kidney Int. 2009 Sep;76(5):534-45. doi: 10.1038/ki.2009.243. Epub 2009 Jul 1.

21.

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D'Agati V, D'Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H.

Kidney Int. 2009 Sep;76(5):546-56. doi: 10.1038/ki.2009.168. Epub 2009 Jul 1.

22.

The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidney.

Advani A, Kelly DJ, Cox AJ, White KE, Advani SL, Thai K, Connelly KA, Yuen D, Trogadis J, Herzenberg AM, Kuliszewski MA, Leong-Poi H, Gilbert RE.

Hypertension. 2009 Aug;54(2):261-9. doi: 10.1161/HYPERTENSIONAHA.109.128645. Epub 2009 Jun 22.

PMID:
19546380
23.

Renal toxicity of therapeutic drugs.

John R, Herzenberg AM.

J Clin Pathol. 2009 Jun;62(6):505-15. doi: 10.1136/jcp.2008.058271. Review.

PMID:
19474353
24.

Loss of TIMP3 enhances interstitial nephritis and fibrosis.

Kassiri Z, Oudit GY, Kandalam V, Awad A, Wang X, Ziou X, Maeda N, Herzenberg AM, Scholey JW.

J Am Soc Nephrol. 2009 Jun;20(6):1223-35. doi: 10.1681/ASN.2008050492. Epub 2009 Apr 30.

25.

Inflammatory pseudotumor of the kidney allograft.

Harel Z, Perl J, Herzenberg AM, Bargman JM.

Am J Kidney Dis. 2009 Sep;54(3):533-7. doi: 10.1053/j.ajkd.2009.01.272. Epub 2009 Apr 19.

PMID:
19376619
26.

Expression, localization, and function of the thioredoxin system in diabetic nephropathy.

Advani A, Gilbert RE, Thai K, Gow RM, Langham RG, Cox AJ, Connelly KA, Zhang Y, Herzenberg AM, Christensen PK, Pollock CA, Qi W, Tan SM, Parving HH, Kelly DJ.

J Am Soc Nephrol. 2009 Apr;20(4):730-41. doi: 10.1681/ASN.2008020142. Epub 2009 Feb 11.

27.

Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease.

Reich HN, Oudit GY, Penninger JM, Scholey JW, Herzenberg AM.

Kidney Int. 2008 Dec;74(12):1610-6. doi: 10.1038/ki.2008.497. Epub 2008 Oct 1.

28.

Kidney involvement in multicentric castleman disease.

Suneja S, Chidambaram M, Herzenberg AM, Bargman JM.

Am J Kidney Dis. 2009 Mar;53(3):550-4. doi: 10.1053/j.ajkd.2008.08.026. Epub 2008 Nov 6. No abstract available.

PMID:
18992980
29.

Tubulointerstitial nephritis as an extraintestinal manifestation of Crohn's disease.

Waters AM, Zachos M, Herzenberg AM, Harvey E, Rosenblum ND.

Nat Clin Pract Nephrol. 2008 Dec;4(12):693-7. doi: 10.1038/ncpneph0955. Epub 2008 Oct 7.

PMID:
18838984
30.

Circadian rhythm disorganization produces profound cardiovascular and renal disease in hamsters.

Martino TA, Oudit GY, Herzenberg AM, Tata N, Koletar MM, Kabir GM, Belsham DD, Backx PH, Ralph MR, Sole MJ.

Am J Physiol Regul Integr Comp Physiol. 2008 May;294(5):R1675-83. doi: 10.1152/ajpregu.00829.2007. Epub 2008 Feb 13. Erratum in: Am J Physiol Regul Integr Comp Physiol. 2008 Jul; 295(1): R369.

31.

Rituximab treatment of idiopathic membranous nephropathy.

Fervenza FC, Cosio FG, Erickson SB, Specks U, Herzenberg AM, Dillon JJ, Leung N, Cohen IM, Wochos DN, Bergstralh E, Hladunewich M, Cattran DC.

Kidney Int. 2008 Jan;73(1):117-25. Epub 2007 Oct 17.

32.

Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury.

Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, Liu QC, Backx PH, Penninger JM, Herzenberg AM, Scholey JW.

Am J Pathol. 2007 Aug;171(2):438-51. Epub 2007 Jun 28.

33.

Late-onset acute haemorrhagic necrotizing granulomatous adenovirus tubulointerstitial nephritis in a renal allograft.

Alsaad KO, Tobar A, Belanger E, Ahmad M, Cattran DC, Herzenberg AM.

Nephrol Dial Transplant. 2007 Apr;22(4):1257-60. Epub 2007 Jan 31. No abstract available.

PMID:
17267541
34.

Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update.

Alsaad KO, Herzenberg AM.

J Clin Pathol. 2007 Jan;60(1):18-26. Review.

35.

Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis.

Oudit GY, Herzenberg AM, Kassiri Z, Wong D, Reich H, Khokha R, Crackower MA, Backx PH, Penninger JM, Scholey JW.

Am J Pathol. 2006 Jun;168(6):1808-20.

36.

Population based survival data on urachal tumors.

Pinthus JH, Haddad R, Trachtenberg J, Holowaty E, Bowler J, Herzenberg AM, Jewett M, Fleshner NE.

J Urol. 2006 Jun;175(6):2042-7; discussion 2047.

PMID:
16697798
37.

Renal pathology in idiopathic membranous nephropathy: a new perspective.

Troyanov S, Roasio L, Pandes M, Herzenberg AM, Cattran DC.

Kidney Int. 2006 May;69(9):1641-8.

39.

Albumin activates ERK via EGF receptor in human renal epithelial cells.

Reich H, Tritchler D, Herzenberg AM, Kassiri Z, Zhou X, Gao W, Scholey JW.

J Am Soc Nephrol. 2005 May;16(5):1266-78. Epub 2005 Apr 13.

40.

A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy.

Zhu X, Herzenberg AM, Eskandarian M, Maguire GF, Scholey JW, Connelly PW, Ng DS.

Am J Pathol. 2004 Oct;165(4):1269-78.

41.

Necrotizing glomerulonephritis caused by Bartonella henselae endocarditis.

Bookman I, Scholey JW, Jassal SV, Lajoie G, Herzenberg AM.

Am J Kidney Dis. 2004 Feb;43(2):e25-30.

PMID:
14750122
42.

C4d deposition in acute rejection: an independent long-term prognostic factor.

Herzenberg AM, Gill JS, Djurdjev O, Magil AB.

J Am Soc Nephrol. 2002 Jan;13(1):234-41.

43.

Heavy chain deposition disease: recurrence in a renal transplant and report of IgG(2) subtype.

Herzenberg AM, Kiaii M, Magil AB.

Am J Kidney Dis. 2000 May;35(5):E25.

PMID:
10793054
44.

Idiopathic nodular glomerulosclerosis.

Herzenberg AM, Holden JK, Singh S, Magil AB.

Am J Kidney Dis. 1999 Sep;34(3):560-4.

PMID:
10469869
45.

Thrombotic microangiopathy associated with cryoglobulinemic membranoproliferative glomerulonephritis and hepatitis C.

Herzenberg AM, Telford JJ, De Luca LG, Holden JK, Magil AB.

Am J Kidney Dis. 1998 Mar;31(3):521-6.

PMID:
9506691
46.

Monoclonal heavy chain (immunoglobulin G3) deposition disease: report of a case.

Herzenberg AM, Lien J, Magil AB.

Am J Kidney Dis. 1996 Jul;28(1):128-31.

PMID:
8712207

Supplemental Content

Loading ...
Support Center